The COMET, LORD, and LORIS clinical trials are investigating the role of active surveillance in low‐risk ductal carcinoma in situ (DCIS). The objective of this study was to identify the… Click to show full abstract
The COMET, LORD, and LORIS clinical trials are investigating the role of active surveillance in low‐risk ductal carcinoma in situ (DCIS). The objective of this study was to identify the proportion of patients eligible for these trials amongst a cohort of patients treated at our institution.
Keywords:
proportion patients;
clinical trials;
ductal carcinoma;
carcinoma situ
Journal Title: Journal of Surgical Oncology
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Surgical Oncology
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!